Financial statements Loximide

Balance sheet of Loximide

Company age:
Age:
20 y. 23 d.
Share capital:
Share capital:
100 000 PLN

Balance sheet data of LOXIMIDE

Year
2018
2019
2020
2021
Total assets 9 049 218,88 13 161 875,66 14 565 687,94 18 575 649,81
A. Fixed assets 41 508,61 881 237,33 832 830,79 772 291,76
B. Current assets 9 007 710,27 12 280 638,33 13 732 857,15 17 803 358,05
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 9 049 218,88 13 161 875,66 14 565 687,94 18 575 649,81
A. Equity 5 073 186,88 6 559 742,66 9 453 024,20 12 459 063,42
B. Liabilities and provisions for liabilities 3 976 032,00 6 602 133,00 5 112 663,74 6 116 586,39
I. Long-term liabilities 0,00 0,00 0,00 0,00
II. Short-term liabilities 3 695 285,30 6 283 166,88 4 722 541,89 6 098 739,04
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.